# BV Financial, Inc.: overview BVFL · Nasdaq · CIK 1302387 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bvfl.md) · [Financials](/companies/bvfl/financials.md) · [Filings](/companies/bvfl/filings.md) · [Insiders](/companies/bvfl/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.35](/filings/0001193125-25-279386.md) | not reported | [0.21](/filings/0001193125-26-216089.md) | [0.29](/filings/0001193125-26-346096.md) | [0.41](/filings/0001193125-25-279386.md) | not reported | [0.13](/filings/0001193125-26-216089.md) | [0.42](/filings/0001193125-26-346096.md) | | Free cash flow | $k | [5,958 d](/filings/0001193125-25-279386.md) | [3,916 d](/filings/0001193125-26-128285.md) | [4,590](/filings/0001193125-26-216089.md) | [4,262 d](/filings/0001193125-26-346096.md) | [6,364 d](/filings/0001193125-25-279386.md) | [3,307 d](/filings/0001193125-26-128285.md) | [3,680](/filings/0001193125-26-216089.md) | [4,323 d](/filings/0001193125-26-346096.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.32](/filings/0000950170-24-035306.md) | [1.47](/filings/0000950170-25-045947.md) | [1.09](/filings/0001193125-26-128285.md) | [1.43](/filings/0001193125-26-128285.md) | | Free cash flow | $m | [9.2](/filings/0000950170-24-035306.md) | [15.0](/filings/0000950170-25-045947.md) | [15.5](/filings/0001193125-26-128285.md) | [18.8](/filings/0001193125-26-128285.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bvfl/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $14.6m | 764,934 | | Reduced −70,231 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $12.6m | 593,526 | | Added +26,181 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.5m | 305,938 | | Reduced −65,519 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $3.7m | 174,351 | | Added +8,843 | | [GENDELL JEFFREY L](/funds/1056581.md) | 2026-06-30 | $3.0m | 141,262 | | Unchanged | | [Oppenheimer & Close, LLC](/funds/1591377.md) | 2026-06-30 | $2.8m | 134,533 | | Unchanged | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $2.7m | 128,692 | | Added +7,759 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $2.4m | 115,248 | | Unchanged | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.1m | 100,798 | | Reduced −5,244 | | [STILWELL VALUE LLC](/funds/1397076.md) | 2026-06-30 | $1.7m | 80,000 | | Reduced −10,000 | ## Recent filings [All 184 filings](/companies/bvfl/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 09:26 ET | [8-K](/filings/0001193125-26-429564.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-429564 | | 2026-08-12 | 11:21 ET | [10-Q](/filings/0001193125-26-346096.md) | Quarterly report, period 2026-06-30 | 0001193125-26-346096 | | 2026-07-24 | 14:39 ET | [8-K](/filings/0001193125-26-315814.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-315814 | | 2026-06-01 | 11:20 ET | [8-K](/filings/0001193125-26-250363.md) | 8.01 Other events | 0001193125-26-250363 | | 2026-05-11 | 11:20 ET | [10-Q](/filings/0001193125-26-216089.md) | Quarterly report, period 2026-03-31 | 0001193125-26-216089 | | 2026-05-08 | 14:11 ET | [8-K](/filings/0001193125-26-214197.md) | 5.07 Shareholder vote results | 0001193125-26-214197 | | 2026-05-06 | 16:35 ET | [8-K](/filings/0001193125-26-209167.md) | 8.01 Other events | 0001193125-26-209167 | | 2026-04-24 | 16:25 ET | [8-K](/filings/0001193125-26-177364.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-177364 | | 2026-04-02 | 14:20 ET | [DEF 14A](/filings/0001193125-26-139683.md) | Proxy statement, period 2026-04-02 | 0001193125-26-139683 | | 2026-03-27 | 13:06 ET | [10-K](/filings/0001193125-26-128285.md) | Annual report, period 2025-12-31 | 0001193125-26-128285 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-128285.md), filed Mar 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1302387 - Tickers: BVFL - Exchange: Nasdaq - SIC code: 6035 Savings Institution, Federally Chartered - State of incorporation: MD - Filer category: Non-accelerated filer
Smaller reporting company
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.